...ics(2011)36,1–9doi:10.1111/j.1365-2710.2009.01150.xREVIEWARTICLEQuadrivalenthumanpapillomavirus(HPV)vaccine:areviewofsafety,ef cacy,andpharmacoeconomicsT.C.PomfretPharmDBCPS,J.M.GagnonJrPharmDBCPSandA.T.Gilc...
...PROPRIETARY MEDICINAL PRODUCTS(CPMP)NOTE FOR GUIDANCE ON HARMONISATION OF REQUIREMENTSFOR INFLUENZA VACCINESDISCUSSION IN THE BIOTECHNOLOGY WORKING PARTY(BWP)TRANSMISSION TO THE CPMPTRANSMISSION TO INTERESTE...
Paediatric rheumatologyIn uenza A H1N1/2009 vaccine in juvenile dermatomyositis:reduced immunogenicity in patients underimmunosuppressive therapyV.R. G...
Virus-like particles: Designing an eVective AIDS vaccineKelly R. Younga,1, Sean P. McBurneya,b, Lukena U. Karkhanisa, Ted M. Rossa,b,¤bDepartment of Me...
RESEARCH|REPORTSonstratethattheCD4TcellimmunopathologyobservedwiththeLM-GP61vaccinewasnotspe-cifictothevaccineplatform,targetepitope,orhostgeneticbackground.Wenextanalyzedadaptiveimmu...
Hepatitis b vaccine1
Proteomics-Based Identification ofAnchorless Cell Wall Proteins as Vaccine Candidates against Staphylococcus aureus Eva Glowalla, Bettina Tosetti, Martin Krönke and Oleg...
Vaccine32(2014)3431–3437ContentslistsavailableatScienceDirectVaccinejournalhomepage:www.elsevier.com/locate...
ReseaRch PaPeRhuman Vaccines & Immunotherapeutics 9:8, 1–6; July 2013; © 2013 Landes BioscienceAssociation between mic...